395 related articles for article (PubMed ID: 24607336)
1. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome.
Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336
[TBL] [Abstract][Full Text] [Related]
2. Correlation of nerve ultrasound, electrophysiological, and clinical findings in post Guillain-Barré syndrome.
Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
J Peripher Nerv Syst; 2013 Sep; 18(3):232-40. PubMed ID: 24028191
[TBL] [Abstract][Full Text] [Related]
3. Serial peripheral nerve ultrasound in Guillain-Barré syndrome.
Razali SNO; Arumugam T; Yuki N; Rozalli FI; Goh KJ; Shahrizaila N
Clin Neurophysiol; 2016 Feb; 127(2):1652-1656. PubMed ID: 26228791
[TBL] [Abstract][Full Text] [Related]
4. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
Verma R; Chaudhari TS; Raut TP; Garg RK
J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound and electrophysiologic findings in patients with Guillain-Barré syndrome at disease onset and over a period of six months.
Grimm A; Décard BF; Schramm A; Pröbstel AK; Rasenack M; Axer H; Fuhr P
Clin Neurophysiol; 2016 Feb; 127(2):1657-1663. PubMed ID: 26220732
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonography of the peripheral nervous system in the early stage of Guillain-Barré syndrome.
Grimm A; Décard BF; Axer H
J Peripher Nerv Syst; 2014 Sep; 19(3):234-41. PubMed ID: 25418824
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome.
DiCapua DB; Lakraj AA; Nowak RJ; Robeson K; Goldstein J; Patwa H
J Clin Neuromuscul Dis; 2015 Dec; 17(2):47-51. PubMed ID: 26583489
[TBL] [Abstract][Full Text] [Related]
8. CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome.
Petzold A; Brettschneider J; Jin K; Keir G; Murray NM; Hirsch NP; Itoyama Y; Reilly MM; Takeda A; Tumani H
Muscle Nerve; 2009 Jul; 40(1):42-9. PubMed ID: 19533642
[TBL] [Abstract][Full Text] [Related]
9. CSF neurofilament levels: a potential prognostic marker in Guillain-Barré syndrome.
Petzold A; Hinds N; Murray NM; Hirsch NP; Grant D; Keir G; Thompson EJ; Reilly MM
Neurology; 2006 Sep; 67(6):1071-3. PubMed ID: 17000982
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
11. Nerve ultrasound evaluation of Guillain-Barré syndrome subtypes in northern China.
Liu L; Ye Y; Wang L; Song X; Cao J; Qi Y; Xing Y
Muscle Nerve; 2021 Nov; 64(5):560-566. PubMed ID: 34355400
[TBL] [Abstract][Full Text] [Related]
12. Residual fatigue in Guillain-Barre syndrome is related to axonal loss.
Drenthen J; Jacobs BC; Maathuis EM; van Doorn PA; Visser GH; Blok JH
Neurology; 2013 Nov; 81(21):1827-31. PubMed ID: 24163277
[TBL] [Abstract][Full Text] [Related]
13. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
14. Admission neurophysiological abnormalities in Guillain-Barré syndrome: A single-center experience.
Luigetti M; Servidei S; Modoni A; Rossini PM; Sabatelli M; Lo Monaco M
Clin Neurol Neurosurg; 2015 Aug; 135():6-10. PubMed ID: 26001516
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome: clinical profile and management.
Sudulagunta SR; Sodalagunta MB; Sepehrar M; Khorram H; Bangalore Raja SK; Kothandapani S; Noroozpour Z; Aheta Sham M; Prasad N; Sunny SP; Mohammed MD; Gangadharappa R; Nidsale Sudarshan R
Ger Med Sci; 2015; 13():Doc16. PubMed ID: 26421004
[TBL] [Abstract][Full Text] [Related]
16. Very Early Neurophysiological Study in Guillain-Barre Syndrome.
Jin J; Hu F; Qin X; Liu X; Li M; Dang Y; Dang J
Eur Neurol; 2018; 80(1-2):100-105. PubMed ID: 30347390
[TBL] [Abstract][Full Text] [Related]
17. An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain Barré syndrome.
Gonzalez-Quevedo A; Carriera RF; O'Farrill ZL; Luis IS; Becquer RM; Luis Gonzalez RS
Neurol India; 2009; 57(3):288-94. PubMed ID: 19587469
[TBL] [Abstract][Full Text] [Related]
18. Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome.
Mori A; Nodera H; Takamatsu N; Maruyama-Saladini K; Osaki Y; Shimatani Y; Kaji R
J Neurol Sci; 2016 May; 364():154-9. PubMed ID: 27084237
[TBL] [Abstract][Full Text] [Related]
19. Conduction block--the diagnostic value in the early stage of Guillain-Barre syndrome.
Atanasova D; Ishpekova B; Muradyan N; Novachkova S; Daskalov M
Electromyogr Clin Neurophysiol; 2004 Sep; 44(6):361-4. PubMed ID: 15473348
[TBL] [Abstract][Full Text] [Related]
20. Recurrent Guillain Barre' syndrome.
Das A; Kalita J; Misra UK
Electromyogr Clin Neurophysiol; 2004 Mar; 44(2):95-102. PubMed ID: 15061403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
